Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LSM family member 14B (LSM14B) is a conserved RNA-binding protein that forms messenger ribonucleoprotein (mRNP) complexes and is a key component of P-body-like granules and mitochondria-associated ribonucleoprotein domain (MARDO) in oocytes[1][2][4]. Unlike its paralog LSM14A, which is broadly expressed in somatic cells, LSM14B is oocyte-specific in vertebrates and participates in maternal mRNA storage, stabilization, and translational regulation, including both repression and activation depending on developmental context[1][2][3][4]. LSM14B interacts with a broad array of RNA-binding proteins (such as DDX6, ZAR1, YBX2) and is involved in the assembly of membrane-less compartments impacting oocyte development, maturation, and fertility[2][4]. Recent data highlight its involvement in cancer pathogenesis, with elevated expression linked to poor prognosis in several cancer types, though it is not currently a direct therapeutic target[3]. LSM14B’s essential functions in oocytes and embryo development underscore its critical, lineage-specific role in RNA metabolism and cellular differentiation[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LSM family member 14B (LSM14B).